Presentation Open Access

Design and Characterization of Mutant and Wild-Type Huntingtin Proteins Produced from a Toolkit of Scalable Eukaryotic Expression Systems 2019/06/04

Harding, Rachel


BibTeX Export

@misc{harding_rachel_2019_3383340,
  author       = {Harding, Rachel},
  title        = {{Design and Characterization of Mutant and Wild- 
                   Type Huntingtin Proteins Produced from a Toolkit
                   of Scalable Eukaryotic Expression Systems
                   2019/06/04}},
  month        = jun,
  year         = 2019,
  note         = {{Dr. Harding is the recipient of the Huntington's 
                   Disease Society of America Berman Topper Career
                   Development Fellowship which funds and supports
                   this research, in addition to generous funding
                   from the CHDI Foundation and the Huntington
                   Society of Canada. The SGC is a registered charity
                   (number 1097737) that receives funds from AbbVie,
                   Bayer Pharma AG, Boehringer Ingelheim, Canada
                   Foundation for Innovation, Eshelman Institute for
                   Innovation, Genome Canada through Ontario Genomics
                   Institute [OGI-055], Innovative Medicines
                   Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766],
                   Janssen, Merck KGaA, Darmstadt, Germany, MSD,
                   Novartis Pharma AG, Ontario Ministry of Research,
                   Innovation and Science (MRIS), Pfizer, São Paulo
                   Research Foundation-FAPESP, Takeda, and Wellcome.}},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.3383340},
  url          = {https://doi.org/10.5281/zenodo.3383340}
}
58
80
views
downloads
All versions This version
Views 5858
Downloads 8080
Data volume 1.5 GB1.5 GB
Unique views 5151
Unique downloads 7272

Share

Cite as